Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mac Fadyen, B. V.
Right arrow Articles by Gum, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mac Fadyen, B. V., Jr.
Right arrow Articles by Gum, E. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical and Biological Changes in Liver Function during Intravenous Hyperalimentation

Bruce V. Mac Fadyen, Jr., M.D.

Department of Surgery, University of Texas Health Science Center at Houston, Houston, Texas

Stanley J. Dudrick, M.D.

Department of Surgery, University of Texas Health Science Center at Houston, Houston, Texas

Gustavo Baquero, M.D.

Department of Surgery, University of Texas Health Science Center at Houston, Houston, Texas

Elizabeth T. Gum, B.S.

Department of Surgery, University of Texas Health Science Center at Houston, Houston, Texas

The use of intravenous hyperalimentation (IVH) with 30% dextrose-amino acid solution produces prolonged positive nitrogen (N) balance, weight gain, and normal growth and development, with minimal metabolic complications. Several investigators have recently reported liver fatty metamorphosis with an associated increase in serum liver enzymes during IVH, particularly noticeable in premature infants. However, this effect has not been clearly defined in adult patients, especially in regard to the composition of the solution, the kcs:N ratio of the infused solution, and caloric requirements of the patient. A series of 42 patients were given a standard IVH formula (25% dextrose—4.5% crystalline amino acids) administered continuously through a central venous catheter whose tip was positioned in the superior vena cava. These patients were divided into 3 groups: Group I (27) who had no documented liver pathology. Group II (15) who had liver disease documented by liver biopsy or liver scan, and Group III (9) who were infused with IVH for simple malnutrition alone. All patients received IVH for 3 weeks or longer; the average dose in Groups I and II was 34.9 ± 1.70 (S.E.x) kcal/kg/day and 41.0 ± 3.9 (S.E.x) in Group III. Liver function studies were analyzed once each week during therapy and included serum glutamic oxaloacetic transaminase (SGOT), serum alkaline phosphatase, and serum total bilirubin. There was no statistical change in any of these levels between Groups I, II, and III; however, patients with known liver disease showed a progressive increase in serum liver enzyme levels during IVH therapy. On the other hand, patients in Group III showed an increase in serum liver enzyme levels by the second week, which decreased to preinfusion levels by the third week of IVH therapy. It is concluded from this study that IVH does not statistically alter liver function studies. Serum liver enzyme changes may be due to an abnormally high kcal: N ratio in the solution, excessive infusion of calories, intrinsic liver disease, or infection. Therefore, IVH therapy for patients should be individualized to maximize nutrient utilization with minimal complications.

Journal of Parenteral and Enteral Nutrition, Vol. 3, No. 6, 438-443 (1979)
DOI: 10.1177/014860717900300607


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JPEN J Parenter Enteral NutrHome page
L. A. Leaseburge, N. J. Winn, and P. R. Schloerb
Liver Test Alterations With Total Parenteral Nutrition and Nutritional Status
JPEN J Parenter Enteral Nutr, July 1, 1992; 16(4): 348 - 352.
[Abstract] [PDF]


Home page
Nutr Clin PractHome page
P. L. Kaproth, J. R. Barber, R. Moore, and E. P. Shronts
Parenteral Nutrition in a Bone Marrow Transplant Patient With Hepatic Complications
Nutr Clin Pract, February 1, 1990; 5(1): 18 - 22.
[PDF]


Home page
JPEN J Parenter Enteral NutrHome page
L. A. Lester, R. M. Rothberg, G. Dawson, A. L. Lopez, and Z. Corpuz
Supplemental Parenteral Nutrition in Cystic Fibrosis
JPEN J Parenter Enteral Nutr, May 1, 1986; 10(3): 289 - 295.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. C. Philcox, T. F. Hartley, L. I.G. Worthley, and D. W. Thomas
Serum Amino Acid Concentrations in Patients Receiving Total Parenteral Nutrition with an Amino Acid Plus Dextrose Mixture
JPEN J Parenter Enteral Nutr, September 1, 1984; 8(5): 535 - 541.
[Abstract] [PDF]